Approval · Notice of Compliance 5025 · 1995

SYNALAR: Notice of Compliance 5025

Issued April 18, 1995

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number: 5025
Date: April 18, 1995
Company: Hoffmann-La Roche LimitedMississauga, Ontario, Canada
Product type: Prescription Pharmaceutical
Submission: New Drug Submission (NDS)
Submission class: Admin
Therapeutic class: Corticosteroid

Products in this notice

Brand	DIN	Status today
SYNALAR	02162547	—
SYNALAR	02162539	—
SYNALAR	02162504	Cancelled Post Market
SYNALAR	02162520	—
SYNALAR	02162512	Dormant

Medicinal ingredients

FLUOCINOLONE ACETONIDE 0.01 PER
FLUOCINOLONE ACETONIDE 0.025 PER